Rhumbline Advisers Sutro Biopharma, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 116,099 shares of STRO stock, worth $480,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,099

Previous 94,164 23.29%

Holding current value

$480,649

Previous $532,000 36.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$2.92 - $5.33 $64,050 - $116,913	21,935 Added 23.29%	116,099 $340,000
Q1 2024 May 09, 2024	BUY	$3.27 - $5.65 $8,420 - $14,548	2,575 Added 2.81%	94,164 $532,000
Q4 2023 Feb 08, 2024	SELL	$2.07 - $4.54 $639 - $1,402	-309 Reduced 0.34%	91,589 $392,000
Q3 2023 Nov 09, 2023	BUY	$3.29 - $4.9 $7,402 - $11,025	2,250 Added 2.51%	91,898 $318,000
Q2 2023 Aug 08, 2023	BUY	$4.25 - $5.88 $21,046 - $29,117	4,952 Added 5.85%	89,648 $416,000
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $31,024 - $58,516	6,925 Added 8.9%	84,696 $391,000
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $36,717 - $54,838	6,787 Added 9.56%	77,771 $628,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $7.11 $42,538 - $58,501	8,228 Added 13.11%	70,984 $394,000
Q2 2022 Aug 11, 2022	BUY	$3.41 - $8.95 $25,847 - $67,841	7,580 Added 13.74%	62,756 $327,000
Q1 2022 May 12, 2022	SELL	$7.78 - $15.31 $6,200 - $12,202	-797 Reduced 1.42%	55,176 $454,000
Q4 2021 Feb 10, 2022	BUY	$14.25 - $23.53 $10,502 - $17,341	737 Added 1.33%	55,973 $833,000
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $34,182 - $45,319	2,025 Added 3.81%	55,236 $1.04 Million
Q2 2021 Aug 05, 2021	BUY	$18.03 - $23.82 $431,998 - $570,727	23,960 Added 81.91%	53,211 $989,000
Q1 2021 May 06, 2021	BUY	$20.29 - $27.54 $31,246 - $42,411	1,540 Added 5.56%	29,251 $666,000
Q4 2020 Feb 10, 2021	BUY	$10.16 - $23.98 $73,162 - $172,679	7,201 Added 35.11%	27,711 $602,000
Q3 2020 Nov 12, 2020	BUY	$7.44 - $13.15 $12,923 - $22,841	1,737 Added 9.25%	20,510 $206,000
Q2 2020 Aug 13, 2020	BUY	$7.24 - $11.05 $36,019 - $54,973	4,975 Added 36.06%	18,773 $146,000
Q4 2019 Feb 05, 2020	BUY	$8.15 - $11.39 $1,793 - $2,505	220 Added 1.62%	13,798 $152,000
Q3 2019 Oct 23, 2019	BUY	$7.91 - $11.76 $9,143 - $13,594	1,156 Added 9.31%	13,578 $123,000
Q2 2019 Aug 14, 2019	BUY	$9.69 - $12.23 $120,369 - $151,921	12,422 New	12,422 $141,000

Others Institutions Holding STRO

# of Institutions

128

Shares Held

62.3M

Call Options Held

200

Put Options Held

27.6K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $216M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Sutro Biopharma, Inc. Transaction History